Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Molecular Partners Ag ADR (MOLN)

Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Molecular Partners Ag ADR WAGISTRASSE 14 SCHLIEREN ZURICH V8 8952 CHE

www.molecularpartners.com Employees: 158 P: 41-44-755-7700

Sector:

Medical

Description:

Molecular Partners AG is a clinical-stage biotech company. It involved in developing a new class of custom-built protein drugs known as DARPin(R) therapeutics. Molecular Partners AG is based in SWITZERLAND.

Key Statistics

Overview:

Market Capitalization, $K 191,378
Enterprise Value, $K 118,828
Shares Outstanding, K 40,375
Float, K 37,981
% Float 94.07%
Short Interest, K 16
Short Float 0.04%
Days to Cover 3.47
Short Volume Ratio 0.37
% of Insider Shareholders 5.93%
% of Institutional Shareholders 26.55%

Financials:

Annual Sales, $ 5,650 K
Annual Net Income, $ -61,390 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,790 K
EBIT, $ -70,890 K
EBITDA, $ -68,200 K

Growth:

1-Year Return -5.49%
3-Year Return -25.96%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 10/30/25
Next Earnings Date 03/05/26 [--]
Earnings Per Share ttm -1.92
EPS Growth vs. Prev Qtr 38.81%
EPS Growth vs. Prev Year 28.07%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MOLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.40%
Return-on-Assets % -45.21%
Profit Margin % -1,086.55%
Debt/Equity 0.00
Price/Sales 19,137.80
Price/Cash Flow N/A
Price/Book 1.57
Book Value/Share 2.96
Interest Coverage -1,533.75
60-Month Beta 1.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar